BlackRock’s AIM ImmunoTech Inc. AIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,983
Closed -$85.4K 5576
2025
Q1
$85.4K Hold
6,983
﹤0.01% 4758
2024
Q4
$138K Hold
6,983
﹤0.01% 4647
2024
Q3
$189K Hold
6,983
﹤0.01% 4486
2024
Q2
$260K Hold
6,983
﹤0.01% 4446
2024
Q1
$329K Sell
6,983
-95
-1% -$4.48K ﹤0.01% 4422
2023
Q4
$311K Buy
7,078
+2
+0% +$88 ﹤0.01% 4460
2023
Q3
$322K Buy
7,076
+1
+0% +$46 ﹤0.01% 4483
2023
Q2
$474K Sell
7,075
-1,096
-13% -$73.4K ﹤0.01% 4410
2023
Q1
$351K Buy
8,171
+34
+0.4% +$1.46K ﹤0.01% 4548
2022
Q4
$254K Buy
8,137
+2
+0% +$62 ﹤0.01% 4704
2022
Q3
$473K Sell
8,135
-32
-0.4% -$1.86K ﹤0.01% 4657
2022
Q2
$638K Sell
8,167
-118
-1% -$9.22K ﹤0.01% 4602
2022
Q1
$878K Sell
8,285
-58
-0.7% -$6.15K ﹤0.01% 4624
2021
Q4
$767K Buy
8,343
+61
+0.7% +$5.61K ﹤0.01% 4672
2021
Q3
$1.67M Buy
8,282
+55
+0.7% +$11.1K ﹤0.01% 4325
2021
Q2
$1.77M Sell
8,227
-1,563
-16% -$336K ﹤0.01% 4264
2021
Q1
$2.22M Buy
9,790
+4,682
+92% +$1.06M ﹤0.01% 4187
2020
Q4
$914K Buy
5,108
+81
+2% +$14.5K ﹤0.01% 4155
2020
Q3
$1.08M Buy
5,027
+271
+6% +$58.2K ﹤0.01% 3995
2020
Q2
$1.18M Buy
4,756
+4,651
+4,430% +$1.15M ﹤0.01% 3918
2020
Q1
$27K Hold
105
﹤0.01% 4500
2019
Q4
$6K Hold
105
﹤0.01% 4725
2019
Q3
$8K Hold
105
﹤0.01% 4693
2019
Q2
$46K Hold
105
﹤0.01% 4533
2019
Q1
$74K Hold
105
﹤0.01% 4375
2018
Q4
$84K Buy
105
+1
+1% +$800 ﹤0.01% 4343
2018
Q3
$105K Hold
104
﹤0.01% 4384
2018
Q2
$146K Hold
104
﹤0.01% 4332
2018
Q1
$181K Sell
104
-1
-1% -$1.74K ﹤0.01% 4182
2017
Q4
$160K Hold
105
﹤0.01% 4201
2017
Q3
$149K Hold
105
﹤0.01% 4228
2017
Q2
$230K Sell
105
-7
-6% -$15.3K ﹤0.01% 4160
2017
Q1
$269K Buy
+112
New +$269K ﹤0.01% 4092
2016
Q4
Hold
0
3822
2016
Q3
Hold
0
3798